STOCK TITAN

SOLAI Limited Receives Additional Notice Regarding NYSE Continued Listing Standards

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Negative)
Tags

SOLAI (NYSE:SLAI) received a NYSE notice on April 27, 2026 for not meeting continued listing market cap and equity standards. As of April 24, 2026, its 30‑day average market cap and December 31, 2025 stockholders' equity were each below US$50 million.

The company has 90 days to submit a plan to regain compliance within 18 months. ADSs continue trading, but face potential NYSE suspension or accelerated delisting, including for prior noncompliance with the US$1.00 minimum price standard.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • ADSs continue to be listed and traded on NYSE
  • Company plans to develop and submit NYSE compliance business plan
  • NYSE notice does not affect business operations or SEC reporting
  • Existing contractual obligations remain unaffected by the NYSE notice

Negative

  • Average 30-day market capitalization below US$50 million NYSE threshold
  • Stockholders' equity under US$50 million as of December 31, 2025
  • Risk of NYSE suspension and SEC delisting if plan is not accepted
  • Potential accelerated delisting if ADSs trade below approximately US$0.10
  • Concurrent noncompliance with US$1.00 minimum average price standard
  • Ongoing inclusion on NYSE noncompliant issuers list with .BC indicator

Key Figures

Market cap threshold: US$50 million Equity threshold: US$50 million Plan submission window: 90 calendar days +5 more
8 metrics
Market cap threshold US$50 million Minimum average total market capitalization over 30 trading days for NYSE compliance
Equity threshold US$50 million Minimum stockholders' equity required under NYSE continued listing standards
Plan submission window 90 calendar days Time after April 27, 2026 NYSE notice to submit business plan
Compliance cure period 18 months Period after notice to regain compliance with Market Cap and Equity Criteria
Abnormally low price level US$0.10 Level at which NYSE may view ADS trading as abnormally low for accelerated delisting
Price standard notice date January 29, 2026 Prior NYSE letter on noncompliance with US$1.00 average price standard
30 trading-day period 30 trading days Lookback window used to assess market cap and price standards
Equity reference date December 31, 2025 Date of last reported stockholders' equity cited in NYSE notice

Market Reality Check

Price: $0.7902 Vol: Volume 122,062 is close t...
normal vol
$0.7902 Last Close
Volume Volume 122,062 is close to the 20-day average of 119,183 (relative volume 1.02x). normal
Technical Shares trade below the 200-day MA of 1.10, with price at 0.7718, and sit 72.44% under the 52-week high.

Peers on Argus

No notable peer moves or same-day sector headlines were provided, pointing to a ...

No notable peer moves or same-day sector headlines were provided, pointing to a company-specific NYSE listing compliance issue rather than a broader Technology sector move.

Historical Context

5 past events · Latest: May 22 (Neutral)
Pattern 5 events
Date Event Sentiment Move Catalyst
May 22 Earnings date set Neutral -2.4% Announcement of timing for release of unaudited Q1 2026 financial results.
May 13 AI product sales Positive +5.8% Start of official Solode Neo sales with multi-model AI support and credits.
Apr 29 Board changes Neutral -5.4% Resignation of prior chairman and appointment of new chairman and committee head.
Apr 23 Going-private proposal Positive -13.3% Revised non-binding offer to acquire all shares at cash consideration per ADS.
Apr 21 AI device launch Positive -1.5% Launch of Solode Neo personal AI device with early-bird pricing and privacy focus.
Pattern Detected

Recent news has been mixed, with product and transaction updates sometimes met with negative price reactions, suggesting investor skepticism even toward seemingly positive catalysts.

Recent Company History

Over the last few months, SOLAI issued several notable updates. On April 21, 2026 and May 13, 2026, it launched and then began official sales of its Solode Neo personal AI device, but one of these AI-focused announcements saw a negative 1.54% move. A revised going-private proposal on April 23, 2026 at up to US$3.20 per ADS coincided with a 13.26% decline. Board changes on April 29, 2026 and an earnings date notice on May 22, 2026 also aligned with modest weakness. Today’s NYSE noncompliance notice fits into this backdrop of pressure despite strategic initiatives.

Market Pulse Summary

This announcement details that SOLAI fell below NYSE continued listing standards tied to US$50 milli...
Analysis

This announcement details that SOLAI fell below NYSE continued listing standards tied to US$50 million thresholds for both average market capitalization and stockholders’ equity. The company has 90 calendar days to submit a remediation plan and up to 18 months to regain compliance, while also operating under a separate US$1.00 average price notice. Investors may focus on updates to the NYSE business plan, progress against operational goals, and any future communications on listing status.

Key Terms

american depositary shares
1 terms
american depositary shares financial
"the Company's American Depositary Shares ("ADSs") trade at levels viewed"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

AI-generated analysis. Not financial advice.

AKRON, Ohio, May 26, 2026 /PRNewswire/ -- SOLAI Limited (NYSE: SLAI) (previously traded under "BTCM") ("SOLAI" or the "Company"), a technology-driven personal AI and digital infrastructure provider, today announced that it received a letter from the New York Stock Exchange (the "NYSE"), dated April 27, 2026, notifying the Company that it was not in compliance with applicable market capitalization and equity criteria (the "Market Cap and Equity Criteria") in the NYSE's continued listing standards because, as of April 24, 2026, the Company's (i) average total market capitalization was less than US$50 million over a consecutive 30 trading-day period, and (ii) last reported stockholders' equity as of December 31, 2025 was less than US$50 million.

In accordance with procedures in the NYSE's Listed Company Manual, the Company has 90 calendar days following its receipt of the notice to submit a business plan to the NYSE that demonstrates how the Company intends to regain compliance with the Market Cap and Equity Criteria within 18 months of receipt of the notice. The Company has already acknowledged receipt of the notice and intends to develop and submit such a business plan to the NYSE. The business plan will then be reviewed for final disposition by the NYSE. Any outstanding listing or annual fees must be paid in full before the business plan is submitted to and reviewed by the NYSE.

If the NYSE accepts the plan, the Company will be subject to quarterly monitoring for compliance with the business plan. If the NYSE does not accept the business plan, the Company will be subject to suspension by the NYSE and delisting by the SEC.

Notwithstanding the foregoing, the NYSE may take accelerated delisting action if the Company's American Depositary Shares ("ADSs") trade at levels viewed to be "abnormally low," which the NYSE generally views as trading below US$0.10.

The NYSE notice does not affect the Company's business operations, its U.S. Securities and Exchange Commission reporting requirements, or its contractual obligations. The notice has no immediate impact on the listing of the Company's ADSs, which will continue to be listed and traded on the NYSE, subject to compliance with other NYSE continued listing standards, including the conditions set forth in the NYSE's letter dated January 29, 2026 for noncompliance with the US$1.00 over a 30 trading-day average price standard, and other rights of the NYSE to delist the ADSs. The cure periods under the different standards work independently of each other, and the NYSE could take delisting action under one standard while the Company remains in the cure period for the other. The Company will continue to be included in the list of NYSE noncompliant issuers, and the below compliance (".BC") indicator will continue to be disseminated with the Company's ticker symbol(s). The website posting and .BC indicator will be removed when the Company has regained compliance with all applicable continued listing standards.

About SOLAI Limited

SOLAI Limited (previously known as "BIT Mining Limited") (NYSE: SLAI) (previously traded under "BTCM") is a technology-driven personal AI and digital infrastructure provider. Building upon its historical legacy in digital asset mining and blockchain network operations, the Company is leveraging extensive experience in large-scale hardware deployment, data center operations, and high-performance computing to build the foundational infrastructure for personal AI computing and digital asset ecosystems globally.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "going forward," "outlook" and similar statements. These forward-looking statements include, without limitation, statements regarding the Company's plans to develop and submit a business plan to the NYSE, satisfy applicable requirements under the NYSE Listed Company Manual, and regain compliance with the NYSE's continued listing standards. Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control, which may cause the Company's actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

For further information:

SOLAI Limited
ir@solai.com
ir.solai.com
www.solai.com

Christensen Advisory
Jason Ng
Tel: +852-2117-0861
Email: solai@christensencomms.com

Cision View original content:https://www.prnewswire.com/news-releases/solai-limited-receives-additional-notice-regarding-nyse-continued-listing-standards-302781697.html

SOURCE SOLAI Limited

FAQ

Why did SOLAI (NYSE:SLAI) receive a NYSE continued listing notice in April 2026?

SOLAI received the notice for not meeting NYSE market cap and equity criteria. According to SOLAI, its 30-day average market capitalization and December 31, 2025 stockholders' equity were both below the US$50 million continued listing thresholds.

What are the NYSE market cap and equity requirements impacting SOLAI stock (SLAI)?

The NYSE requires at least US$50 million in average 30-day market cap and US$50 million in stockholders' equity. According to SOLAI, it fell below both levels, triggering a continued listing noncompliance notice on April 27, 2026.

How long does SOLAI have to regain NYSE compliance with SLAI listing standards?

SOLAI has 90 days from the April 27, 2026 notice to submit a business plan. According to SOLAI, the plan must show a path to meeting the market cap and equity criteria within 18 months of receiving the NYSE notice.

Will SOLAI (SLAI) be immediately delisted from the NYSE after this notice?

No, SOLAI’s ADSs continue trading on the NYSE for now. According to SOLAI, there is no immediate delisting, but failure of NYSE plan approval or very low trading prices could lead to suspension and eventual delisting.

How does the NYSE US$1.00 price standard affect SOLAI stock (SLAI)?

SOLAI is also addressing a separate NYSE notice for not meeting the US$1.00 30-day average price standard. According to SOLAI, cure periods for this and the market cap/equity standards operate independently and could trigger delisting under either rule.

What risks do SOLAI shareholders face if SLAI ADSs trade below US$0.10 on the NYSE?

If ADSs trade at levels viewed as abnormally low, generally below US$0.10, the NYSE may accelerate delisting. According to SOLAI, this accelerated action is separate from the standard 18-month compliance plan process.

Does the NYSE noncompliance notice change SOLAI’s operations or contracts?

SOLAI states the NYSE notice does not affect business operations, SEC reporting, or contractual obligations. According to SOLAI, only the listing status and related monitoring, including the .BC noncompliance indicator, are directly impacted by the notice.